Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The GLP-1 Era: Why These Intestinal Peptides Are Reshaping Modern Medicine The implications and actions of these medications go so far beyond weight loss
2024 Feb 22;263(Pt 2):130386
Beginners should focus on understanding what it does, starting with safe dosages, and combining it with a balanced diet and consistent exercise routine .
Disclaimer: This content piece is no substitute for direct medical advice
In a randomised controlled trial with over 1800 participants comparing tirzepatide to semaglutide, the tirzepatide group reported more serious adverse events (5-7% VS 3%) and higher discontinuation rates due to adverse events (6-8.5% VS 4%)
To participate in a fast-growing but competitive and complicated market, GLP-1 originators will need to adopt a differentiated patient- and customer-centric strategy leveraging both internal and external resources to optimize product positioning, building brand equity, integrating software and device solutions beyond the drug itself, and exploring innovative channels
